Data / Form D filings / Alucent Biomedical, Inc.
Alucent Biomedical, Inc.: Form D filings
Alucent Biomedical, Inc., a biotechnology company in Salt Lake City, UT, filed 3 Form D notices with the SEC between 2015 and 2023. The latest, on April 20, 2023, reports $11.2 million sold of a $11.2 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 675 ARAPEEN DRIVE, SUITE 102, Salt Lake City, UT, 84108
- Phone
- (385) 722-2300
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1631834
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 20, 2023 | New notice | $11,200,000 | $11,200,000 | 1 | Apr 17, 2023 | sec.gov | |
| Oct 15, 2020 | New notice | $34,999,999 | $34,999,999 | 3 | Sep 30, 2020 | sec.gov | |
| Jan 27, 2015 | New notice | $400,000 | $400,000 | 1 | Jan 26, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Julie Lautt | Director | |
| James Corbett | Director | |
| Bruce Krattenmaker | Executive Officer | |
| Kevin Warner | Executive Officer | |
| Colin Jackson | Executive Officer | |
| Myles Greenberg | Executive Officer, Director | |
| David Flicek | Director | |
| Katalin Kauser | Executive Officer | |
| Daniel Pelak | Director | |
| Nick Pappas | Director | |
| James Isaacson | Executive Officer | |
| Henry Hauser | Executive Officer |
Other biotechnology companies in Utah that filed recently
- Life Impact Partners 1 LLC offering · Oct 22, 2026
- 3Helix, Inc. $7.8 million · Sep 21, 2026
- Halia Therapeutics, Inc. $3.5 million · Aug 31, 2026
- Paterna BioSciences HoldCo Inc. $6.3 million · Aug 12, 2026
Every Form D from the week of Apr 17, 2023 · All recent filings in Utah · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Alucent Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.